Showing posts with label thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP). Show all posts
Showing posts with label thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP). Show all posts
Friday, May 11, 2018

FDA Approves Tavalisse (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia

›
Rigel Pharmaceuticals, Inc.   announced that the U.S. Food and Drug Administration (FDA) approved  Tavalisse  (fostamatinib disodium hexah...